biote Corp.BTMD

NasdaqHealthcareMedicinal Chemicals & Botanical Products
Price (close)
$1.22
Market cap
$34.9M
P/E
6.0x
Revenue (TTM)
$183.5M
Net income
$5.9M
Dividend yield
—
1-year total return
-58.9%
Net margin
3.2%
Revenue growth
-7.8%
Debt / equity
—

What biote Corp. does.

No business description on file yet.

Revenue and profit, by fiscal year.

Fiscal year202020212022202320242025
Revenue—$139.4M$165.0M$185.4M$197.2M$192.2M
Net income—$11.1M-$969,000$3.3M$3.2M$27.0M
Free cash flow—$32.3M-$9.5M$26.5M$38.8M$30.2M

More on BTMD.

Figures from biote Corp.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.